Very interesting point made by Ranjit Shahani
from Novartis India:
The immense talents in India’s pharmaceutical companies should be focused on R&D of medicines that will help the people and the economy of India that go far beyond simply copying others’ inventions. Without patents there will be few new medicines and without new medicines there will be no new generics.
Read the full editorial here.